Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study
- PMID: 35586746
- PMCID: PMC8973861
- DOI: 10.5334/gh.1112
Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study
Abstract
Background: Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI.
Methods: This prospective observational study included patients who had undergone primary PCI at a tertiary care cardiac center. All the patients were followed at 30-days of index hospitalization for the incidence of acute or sub-acute ST. ST was further categorized as definite, probable, or possible per the Academic Research Consortium definition. All the survivors of ST were followed after 6-months for the incidence of major adverse cardiovascular events.
Results: An aggregate of 1756 patients were included with 79% (1388) male patients and mean age was 55.59 ± 11.23 years. The incidence of ST was 4.9% (86) with 1.3% (22) acute and 3.6% (64) sub-acute. ST was categorized as definite in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were observed to be male gender (odds ratio (OR); 2.51 [1.21-5.2]), left ventricular end-diastolic pressure ≥20 mmHg (OR; 2.55 [1.31-4.98]), and pre-procedure thrombolysis in myocardial infarction (TIMI) flow 0 (OR; 3.27 [1.61-6.65]). Cumulative all-cause mortality among patients with ST after 164.1 ± 76.2 days was 46.5% (40/86).
Conclusion: We observed a substantial number of patients vulnerable to the acute or sub-acute ST after primary PCI. Male gender, LVEDP, pre-procedure TIMI flow grade can be used to identify and efficiently manage highly vulnerable patients.
Keywords: DES; MACE; STEMI; acute; primary PCI; stent thrombosis; sub-acute.
Copyright: © 2022 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Similar articles
-
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011. JACC Cardiovasc Interv. 2013. PMID: 23968698 Clinical Trial.
-
[Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):600-607. doi: 10.3760/cma.j.cn112148-20200327-00254. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32842271 Chinese.
-
Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.Catheter Cardiovasc Interv. 2020 Feb;95(2):E40-E55. doi: 10.1002/ccd.28440. Epub 2019 Aug 18. Catheter Cardiovasc Interv. 2020. PMID: 31423723
-
Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):837-844. doi: 10.1016/j.carrev.2018.03.025. Epub 2018 Apr 3. Cardiovasc Revasc Med. 2018. PMID: 29685385
-
Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis.Am J Cardiovasc Drugs. 2018 Dec;18(6):483-492. doi: 10.1007/s40256-018-0295-y. Am J Cardiovasc Drugs. 2018. PMID: 30132141
Cited by
-
The outcome of primary percutaneous coronary intervention in patients with stent thrombosis.Indian Heart J. 2022 Nov-Dec;74(6):464-468. doi: 10.1016/j.ihj.2022.11.003. Epub 2022 Nov 8. Indian Heart J. 2022. PMID: 36368606 Free PMC article.
-
Characterizing thrombus adhesion strength on common cardiovascular device materials.Front Bioeng Biotechnol. 2024 Aug 14;12:1438359. doi: 10.3389/fbioe.2024.1438359. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39205855 Free PMC article.
-
A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis.Egypt Heart J. 2023 Oct 12;75(1):85. doi: 10.1186/s43044-023-00408-8. Egypt Heart J. 2023. PMID: 37823944 Free PMC article.
-
Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions.J Clin Med. 2023 Nov 28;12(23):7367. doi: 10.3390/jcm12237367. J Clin Med. 2023. PMID: 38068419 Free PMC article. Review.
-
Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review.Cureus. 2023 Sep 13;15(9):e45150. doi: 10.7759/cureus.45150. eCollection 2023 Sep. Cureus. 2023. PMID: 37842458 Free PMC article. Review.
References
-
- Clemmensen P, Wiberg S, Van’t Hof A, et al. Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography). JACC: Cardiovascular Interventions. 2015; 8(1 Part B): 214–20. DOI: 10.1016/j.jcin.2014.11.002 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous